










































CD25+ natural regulatory T cells are critical in limiting innate and
adaptive immunity and resolving disease following respiratory
syncytial virus infection
Citation for published version:
Lee, DCP, Harker, JAE, Tregoning, JS, Atabani, SF, Johansson, C, Schwarze, J & Openshaw, PJM 2010,
'CD25+ natural regulatory T cells are critical in limiting innate and adaptive immunity and resolving disease
following respiratory syncytial virus infection' Journal of Virology, vol 84, no. 17, pp. 8790-8.,
10.1128/JVI.00796-10
Digital Object Identifier (DOI):
10.1128/JVI.00796-10
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:




Copyright © 2010, American Society for Microbiology
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 20. Feb. 2015
JOURNAL OF VIROLOGY, Sept. 2010, p. 8790–8798 Vol. 84, No. 17
0022-538X/10/$12.00 doi:10.1128/JVI.00796-10
Copyright © 2010, American Society for Microbiology. All Rights Reserved.
CD25 Natural Regulatory T Cells Are Critical in Limiting Innate and
Adaptive Immunity and Resolving Disease following
Respiratory Syncytial Virus Infection†
Debbie C. P. Lee, James A. E. Harker,‡ John S. Tregoning,§ Sowsan F. Atabani,¶ Cecilia Johansson,
Ju¨rgen Schwarze, and Peter J. M. Openshaw*
Department of Respiratory Medicine and Centre for Respiratory Infection, National Heart and Lung Institute, Imperial College,
St. Mary’s Campus, Norfolk Place, London W2 1PG, United Kingdom
Received 15 April 2010/Accepted 15 June 2010
Regulatory CD4 T cells have been shown to be important in limiting immune responses, but their role
in respiratory viral infections has received little attention. Here we observed that following respiratory
syncytial virus (RSV) infection, CD4 Foxp3 CD25 natural regulatory T-cell numbers increased in the
bronchoalveolar lavage fluid, lung, mediastinal lymph nodes, and spleen. The depletion of CD25 natural
regulatory T cells prior to RSV infection led to enhanced weight loss with delayed recovery that was
surprisingly accompanied by increased numbers of activated natural killer cells in the lung and bron-
choalveolar lavage fluid on day 8 postinfection. Increased numbers of neutrophils were also detected
within the bronchoalveolar lavage fluid and correlated with elevated levels of myeloperoxidase as well as
interleukin-6 (IL-6) and gamma interferon (IFN-). CD25 natural regulatory T-cell depletion also led to
enhanced numbers of proinflammatory T cells producing IFN- and tumor necrosis factor alpha (TNF-)
in the lung. Despite these increases in inflammatory responses and disease severity, the viral load was
unaltered. This work highlights a critical role for natural regulatory T cells in regulating the adaptive and
innate immune responses during the later stages of lung viral infections.
Regulatory T cells (Tregs) are a subset of CD4 T cells
that are capable of regulating and suppressing the immune
system (15). A number of Treg subsets have now been de-
scribed, including naturally occurring Tregs (nTregs), which
develop in the thymus, and inducible Tregs, which are in-
duced in the periphery following encounters with antigen-
loaded dendritic cells. The precise inhibitory mechanisms
used by Tregs are not fully elucidated but can involve direct
cell-cell contact or the secretion of various cytokines such as
interleukin-10 (IL-10) and transforming growth factor 
(TGF-) (24).
The importance of Tregs in autoimmunity, allergy, and,
more recently, bacterial and viral infections has been demon-
strated (2, 10). Tregs can be both beneficial and detrimental to
the host during infection, controlling excessive host immune
responses, e.g., herpes simplex virus (14), but potentially en-
hancing pathogen survival and in some cases allowing the long-
term persistence of a pathogen, e.g., Plasmodium yoelii (8).
However, far less is known about the role that nTregs play
during acute viral lung infections.
Respiratory syncytial virus (RSV) is the most important
cause of acute respiratory tract viral infections in infants and
the leading cause of viral bronchiolitis and infantile hospital-
izations in the developed world (22). RSV disease is caused in
part by a large inflammatory infiltrate into the lungs that is
comprised of both natural killer (NK) cells and T cells. In mice,
RSV infection leads to the early recruitment of NK cells into
the lungs and airways during the first few days (9). This is
followed by the recruitment of CD4 and CD8 effector T cells,
the levels of which peak between days 7 and 10 postinfection
(p.i.) (18, 23). However, the role of nTregs has yet to be fully
explored. Using the CB6F1 hybrid mouse model for RSV in-
fection, Ruckwardt et al. showed previously that Treg deple-
tion delays CD8 T cell responses in the lung and can modu-
late the disparities between dominant and subdominant
epitopes (20).
Here we demonstrate that RSV infection leads to in-
creased nTreg numbers in the lung, bronchoalveolar lavage
(BAL) fluid, mediastinal lymph node (MLN), and spleen.
The depletion of CD25 nTregs resulted in enhanced dis-
ease severity that was characterized by increases in weight
loss, the recruitment of innate cells to the bronchoalveolar
lavage (BAL) fluid and lung, and increased levels of CD4
and CD8 T cells producing gamma interferon (IFN-).
Despite this enhanced immune response, Treg depletion did
not affect viral load in the lungs, and although recovery was
delayed, it was not prevented. These data indicate that
nTregs play a critical role in regulating the adaptive and
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innate immune responses to acute infection and in resolving
inflammation following viral clearance.
MATERIALS AND METHODS
Mice and virus stocks. Eight-week-old female BALB/c mice (Charles River
Laboratories, Inc., United Kingdom) were maintained under pathogen-free con-
ditions in accordance with institutional and United Kingdom Home Office guide-
lines. Plaque-purified human RSV (type A2 strain from the ATCC) was grown in
HEp-2 cells with RPMI 1640 medium supplemented with 2% fetal bovine serum,
2 mM L-glutamine, 100 U/ml penicillin, and 100 g/ml streptomycin.
Mouse infection and treatment. Mice were infected intranasally (i.n.) with 100
l of 6  105 PFU of RSV while under light anesthesia. Following infection,
weight change was monitored daily. For Treg depletion, mice were treated with
250 l of 1 mg/ml anti-CD25 (clone PC61) antibody, isotype control antibody
(clone GL113) (kind gifts from A. Gallimore, Cardiff University), or phosphate-
buffered saline (PBS) via intraperitoneal (i.p.) injection on days 3 and 1 prior
to infection.
Cell collection and preparation. After infection, animals were sacrificed by i.p.
pentobarbitone injection. BAL was performed by the inflation of the lungs via
the trachea three times with 1 ml of 12 mM lidocaine in Eagle’s minimum
essential medium. An aliquot of BAL fluid cells was transferred onto a micro-
scope slide (Thermo Scientific, United Kingdom) using a cytospin centrifuge and
stained with hematoxylin and eosin (H&E) (Reagena, Gamidor, United King-
dom) for cellular differentiation, and the rest of the cells were prepared for flow
cytometry. BAL fluid cell-free supernatant was retained for enzyme-linked im-
munosorbent assay (ELISA). One half of the lung tissue was chopped finely
using blades and digested in collagenase (50 g/ml) for 30 min at 37°C, and red
blood cell lysis was performed by using ACK lysing buffer (0.15 M NH4Cl, 1 mM
KHCO3, 1 mM Na2 EDTA [pH 7.2]) for 5 min at room temperature. Total cells
were quantified and prepared for flow cytometry. The second half of the lung
tissue was homogenized and used for an RSV infectious focus assay and for
quantitative PCR (qPCR) for the RSV L gene to measure viral load.
Flow cytometric analysis. Prepared cells were blocked with Fc block (anti-
CD16/32; BD, United Kingdom), and cell surface staining was performed on live
cells resuspended in PBS containing 1% bovine serum albumin, 0.1% azide, and
5 M EDTA (flow buffer). For intracellular Foxp3 staining, cells were fixed and
permeabilized according to the manufacturer’s instructions (eBioscience, United
Kingdom). For intracellular IFN- and tumor necrosis factor alpha (TNF-)
analysis, cells were stimulated for 4 h with phorbol 12-myristate 13-acetate
(PMA) (50 mg/ml) and ionomycin (500 ng/ml) (Sigma, United Kingdom) or the
M2 peptide (Pro-Immune, United Kingdom) and interleukin-2 (IL-2) (50 U/ml)
(R&D Systems, United Kingdom), as described previously (3), in the presence of
GolgiPlug (BD, United Kingdom). The following antibodies were used and
purchased from BD (United Kingdom), unless otherwise stated: anti-CD3-phy-
coerythin (PE)-Cy7, anti-CD4-peridinin chlorophyll protein (PerCP), anti-CD8-
Pacific blue, anti-CD25-PE, anti-DX5-PE, anti-CD69-fluorescein isothiocyanate
(FITC), anti-TNF-–PE, anti-IFN-–FITC, and anti-Foxp3-allophycocyanin
(APC) (eBioscience, United Kingdom). Cells were run on a Cyan ADP LX 9
color flow cytometer (Dako, United Kingdom), and data were analyzed by using
the Dako Summit analysis program.
Cytokine ELISA. Cytokines levels were quantified by ELISA according to the
manufacturer’s instructions. IL-6 was assessed by using antibody pairs from R&D
Systems (United Kingdom), myeloperoxidase (MPO) was assessed by using a
mouse MPO ELISA kit containing precoated plates from Hycult Biotechnology,
and IFN- was assessed by using paired antibodies from BD (United Kingdom).
Briefly, Immunosorb ELISA plates (Nunc, United Kingdom) were coated with
capture antibody overnight at 4°C. Wells were washed and blocked with 1%
bovine serum albumin in PBS for 1 h at room temperature. A sample or standard
was added for 2 h at 37°C, and bound cytokine was detected by using biotinylated
anti-cytokine antibody, avidin horseradish peroxidase, and tetramethylbenzidine.
Color development was stopped with 2 M H2SO4, and optical densities were read
at 450 nm. The concentration of the cytokine was determined from the standard
curve.
Quantification of viral RNA. Total RNA was extracted from lung tissue by
using RNA STAT-60 (AMS Biotechnology Ltd., United Kingdom), and cDNA
was generated by using random hexamers and Ominscript reverse transcriptase
(Qiagen, United Kingdom). qPCR was performed for the RSV L gene using
900 nM forward primer (5-GAACTCAGTGTAGGTAGAATGTTTGCA-3),
300 nM reverse primer (5-TTCAGCTATCATTTTCTCTGCCAAT-3), and
175 nM probe (5-6-carboxyfluorescein-TTTGAACCTGTCTGAACATTCCCG
GTT-6-carboxytetramethylrhodamine-3) with an ABI Prism 7500 sequence de-
tection system as previously described (5). RSV L gene copies were normalized
to the 18S rRNA housekeeping gene.
Statistical analysis. Results are expressed as means 	 standard errors of the
means (SEM). Statistical analysis was performed by using analysis of variance
(ANOVA) followed by the Bonferroni test if P values were significantly different




Primary RSV infection leads to an increase in nTregs.
BALB/c mice were infected intranasally (i.n.) with 6  105
PFU of RSV, and weight was monitored daily. Mice lost weight
from day 4 postinfection (p.i.), with the peak of weight loss
being detected at day 6 p.i. (see Fig. S1A in the supplemental
material). The percentage of CD3 CD4 Foxp3 CD25
nTregs in the bronchoalveolar lavage (BAL) fluid, lungs, me-
diastinal lymph node (MLN), and spleen was determined by
flow cytometry with naïve mice at days 1, 2, 4, 8, 16, and 28 p.i.
(Fig. 1A). Following infection, both total CD3 CD4 T cells
and CD4 Foxp3 CD25 nTregs were detected in the BAL
fluid on days 4 and 8 p.i., with no CD4 Foxp3 CD25
nTregs being detected in the BAL fluid of naïve mice (Fig. 1B
and C). This corresponded to a significant increase in the
number of cells detected in the BAL fluid from day 4 onwards
(Fig. S1B). In lungs of naïve mice, CD4 Foxp3 CD25
nTregs comprised 4 to 5% of CD3 CD4 T cells, in line with
previous findings for peripheral nTreg proportions (21). Infec-
tion with RSV led to a gradual increase in the percentage of
lung CD4 Foxp3 CD25 nTregs from day 2 p.i. onward,
peaking at day 8 p.i. (Fig. 1E). This correlated with a rise in
CD3 CD4 T cell numbers in the lung starting at day 4 p.i.
(Fig. 1D) as well as a general influx of cells into the lung (Fig.
S1C). As with the lungs, there were increased numbers of
CD3 CD4 T cells detected in the MLN following infection
(Fig. 1F). The peak of CD4 Foxp3 CD25 nTregs in the
MLN occurred earlier (day 4 p.i.), prior to the peak seen for
the lung (Fig. 1G). Interestingly, on day 28 p.i., there was a
second significant peak in the percentage of CD4 Foxp3
CD25 nTregs in the MLN. For the spleen, we did not detect
any differences in the total numbers of CD3 CD4 cells (Fig.
1H), although there was a significant increase in the percent-
age of CD4 Foxp3 CD25 nTregs at days 2, 4, 8, and 16 p.i.
(Fig. 1I). The percentage of CD4 Foxp3 CD25 cells
showed a pattern similar to that of CD4 Foxp3 CD25
nTregs in each tissue throughout the infection. However, the
percentage of this population remained at a low level and
below 4% for each of the tissues studied, except for the BAL
fluid at days 4 and 8 p.i. (Fig. S2A to S2D). From this, we
observed that primary RSV infection leads to increased fre-
quencies of CD4 Foxp3 CD25 nTregs in the BAL fluid,
lungs, MLN, and spleen.
Anti-CD25 antibody treatment prior to infection results in
enhanced RSV disease and the recruitment of innate effector
cells. To determine the effects of depleting CD4 Foxp3
CD25 nTregs prior to RSV infection, BALB/c mice were
treated with either anti-CD25 antibody (PC61), isotype control
antibody (GL113), or PBS 3 days and 1 day prior to RSV
infection. This treatment resulted in the depletion of 73 to 75%
of CD4 Foxp3 CD25 nTregs from the lungs and complete
depletion from the BAL fluid (Fig. 2A, B, and C). Treatment
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FIG. 1. Identification and enumeration of nTregs during RSV infection. Adult BALB/c mice were infected i.n. with RSV or left naïve. At the
indicated time points p.i., mice were sacrificed, and BAL fluid, lung, MLN, and spleen cells were stained for CD3, CD4, CD25, and Foxp3 and
analyzed by flow cytometry. (A) Representative plots show CD4 T cells, Foxp3 CD25 nTregs, and the isotype control staining for Foxp3 in
the lung at day 8 p.i. (B to I) The total numbers of CD4 T cells and the percentages of Foxp3 CD25 nTregs were measured in the BAL fluid
(B and C), the lung (D and E), the MLN (F and G), and the spleen (H and I). Symbols represent individual animals, and the horizontal bars
represent the means (n 5). *, P
 0.05; **, P
 0.01; ***, P
 0.001 (for RSV-infected compared with naïve control mice). The graph represents
data from one of two similar independent experiments. ns, not significant.
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with anti-CD25 antibody did not affect the percentage of
CD4 Foxp3 CD25 cells detected at day 4 p.i. in the BAL
fluid or lung compared to control groups (Fig. 2D). However,
at day 8 p.i. the percentage of CD4 Foxp3 CD25 cells in
the anti-CD25-treated group was significantly higher for the
lung but not the BAL fluid (Fig. 2E).
All infected mice started to lose weight from day 6 p.i., but
weight loss was greatest for the anti-CD25-treated group,
FIG. 2. Effective nTreg depletion using anti-CD25 antibody. Adult BALB/c mice were injected i.p. with PBS, isotype control antibody, or
anti-CD25 antibody on days 3 and 1 prior to RSV infection. Twenty-four hours after the second injection, mice were infected i.n. with 6  105
PFU of RSV. Mice were sacrificed on day 4 or 8 p.i., and cells were stained as described in the legend of Fig. 1. (A) Representative plots show
lung CD4 T cells and Foxp3 CD25 nTregs from each treatment group on day 4 p.i. (B to E) The percentages of CD4 Foxp3 CD25 nTregs
and CD4 Foxp3 CD25 cells in the BAL fluid (B and D) and the lung (C and E) were determined. Bars represent means 	 SEM (n  5). *,
P 
 0.05; **, P 
 0.01 (for the anti-CD25-depleted group compared to the PBS and isotype control groups). The graphs represent data from one
of two similar independent experiments.
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peaking at over 20% of the original body weight on day 8 p.i.
Perhaps more striking was the sustained weight loss at over
20% for 3 days in the anti-CD25 treated group compared to
the control groups, which began to recover the day after (Fig.
3A). The depletion of CD4 Foxp3 CD25 nTregs also led to
a significant increase in the number of viable cells detected in
the BAL fluid and the lungs compared to controls on day 8 but
not day 4 p.i. (Fig. 3B and C).
Having demonstrated that nTregs are important in limiting
RSV-induced disease, we investigated their influence on the
recruitment of innate effector cells. It was previously demon-
strated that NK cells and neutrophils are recruited during RSV
infection in both humans (16) and mice (18). During a primary
RSV infection in mice, the peak of NK cells occurs on day 4 p.i.
in the lung before declining (18). Following treatment with
anti-CD25 antibody, the numbers of NK cells detected on day
4 p.i. were similar for all groups for both the BAL fluid and
lung. However, surprisingly, at day 8 p.i. treatment with anti-
CD25 antibody led to a significant increase in the number of
NK cells detected within the BAL fluid and lung (Fig. 4A and
C). Moreover, the NK cells detected on day 8 in the CD25-
depleted group were found to be more activated in the BAL
fluid and lung, as indicated by an increased percentage of
CD69 expression compared to NK cells in the control groups.
This is in contrast to the NK cells detected on day 4 p.i., where
CD69 expression levels were similar between the groups (Fig.
4B and D). In addition, on day 8 p.i. there was also a 5-fold
increase in the number of neutrophils in the BAL fluid of
CD25-depleted mice compared to controls (Fig. 4F). Neutro-
phils are usually detected during the early stages of infection
on days 1 and 2 (see Fig. S1D in the supplemental material).
RSV-infected non-CD25-depleted mice had very low numbers
of neutrophils on day 4 (Fig. 4E) and day 8 (Fig. 4F) p.i.
Furthermore, levels of macrophages and lymphocytes in the
BAL fluid were also increased on day 8 p.i. in CD25-depleted
mice but to a lesser degree, and there was no effect on eosin-
ophil recruitment (Fig. 4F). In the BAL fluid of naïve mice that
were CD25 depleted, only macrophages were detected (data
not shown). The enhanced numbers of NK cells and neutro-
phils were accompanied by elevated levels of myeloperoxidase
(MPO), the proinflammatory cytokine IL-6, and IFN- in the
BAL fluid on day 8 p.i. (Fig. 4G, H, and I). However, despite
the presence of elevated numbers of innate antiviral immune
cells, nTreg depletion did not alter the viral load on day 4 or
8 p.i., as measured by qPCR (Fig. 4J) and an immunoplaque
assay (data not shown). It therefore appears that nTregs limit
weight loss and innate effector cell recruitment to the lung
following RSV infection without affecting the control of viral
replication.
Depletion of nTregs prior to RSV infection leads to in-
creased adaptive T cell responses in the lung. Previous studies
using murine models of primary RSV infection showed that T
cell numbers increase from day 4 p.i. and peak at around day
7 or 8 p.i. (18). Following anti-CD25 antibody treatment, the
numbers of both CD4 and CD8 T cells in the lung rose
significantly on day 8 p.i. compared to control groups (Fig. 5A
and B). The percentages of activated CD4 and CD8 T cells,
as measured by CD69 expression, were similar for all three
groups, indicating that cell activity was not altered by anti-
CD25 antibody treatment (Fig. 5C and D). Despite compara-
ble levels of activation, ex vivo stimulation of lung cells with
PMA and ionomycin resulted in more CD4 and CD8 T cells
producing IFN- in the CD25-depleted group than in controls
(Fig. 5E, and see Fig. S3B and S3C in the supplemental ma-
terial). Furthermore, following ex vivo stimulation, there were
more CD4 T cells in the CD25-depleted mice that produced
both IFN- and TNF- (Fig. 5F and Fig. S3B), while no dif-
ference was seen in CD8 T cells (Fig. S3B and S3D). There
was also no difference in the percentage of CD4 or CD8 T
cells producing TNF- alone (data not shown). To assess the
RSV-specific response, lung cells were stimulated using the
immunodominant RSV-M2 major histocompatibility complex
(MHC) class I peptide (SYIGSINNI) in combination with
IL-2, as described previously (3). CD8 T cells from anti-
CD25-depleted mice stimulated with this peptide coproduced
significantly higher levels of TNF- and IFN- (Fig. 5H), while
no change was detected in the percentages of CD8 T cells
producing IFN- alone (Fig. 5G) or TNF- alone (data not
shown). Therefore, the depletion of CD4 Foxp3 CD25
FIG. 3. Enhanced RSV disease following nTreg depletion. (A) Following treatment with PBS, isotype control antibody, or anti-CD25 antibody
prior to RSV infection, weight change was monitored daily and plotted as a percentage of the weight on the day of infection. (B and C) The total
viable BAL fluid (B) and lung (C) cell numbers were enumerated by using light microscopy. Symbols and bars represent means 	 SEM (n  5).
*, P
 0.05; **, P
 0.01; ***, P
 0.001 (for the anti-CD25-depleted group compared to the PBS and isotype control groups)., P
 0.05;,
P 
 0.001 (for PBS versus anti-CD25 depletion). , P 
 0.05; , P 
 0.001 (for isotype control versus anti-CD25 depletion). The graphs
represent data from one of two similar independent experiments.
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FIG. 4. nTreg depletion leads to sustained innate immune responses. Adult BALB/c mice received anti-CD25 antibody, isotype control
antibody, or PBS prior to RSV infection. (A to D) Mice were sacrificed on days 4 and 8 p.i., and lung cells were analyzed by flow cytometry for
NK cell (CD3 DX5) numbers and activation (CD69) in the BAL fluid (A and B) and lung (C and D). (E and F) BAL fluid cells were taken,
and H&E staining was performed to carry out differential cell counts for macrophages, lymphocytes, neutrophils, and eosinophils on days 4 (E) and
8 (F) p.i. (G to I) Levels of MPO (G), IL-6 (H), and IFN- (I) in the BAL fluid were measured by ELISA on day 8 p.i. (J) RSV L gene copy
numbers were determined by qPCR of lung tissue on days 4 and 8 p.i. The dotted line represents the detection limit of the assays. Symbols represent
individual animals, and the horizontal bars represent the means. Bars represent means 	 SEM (n  5). *, P 
 0.05; **, P 
 0.01; ***, P 
 0.001
(for PBS- and isotype control-treated groups compared to the anti-CD25-depleted group). The graphs represent data from one of two similar
independent experiments.
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nTregs increases the recruitment of proinflammatory T cells to
the lung following RSV infection.
DISCUSSION
While the role of effector T cells during RSV infection has
been well studied, less is known about the role of regulatory T
cells. We initially showed that during the course of a primary
RSV infection, numbers of CD4 Foxp3 CD25 nTregs in-
creased in the BAL fluid, MLN, lung, and spleen, with peaks
on day 4 p.i. in the BAL fluid and MLN, on day 8 in the lung,
and from days 2 to 8 p.i. in the spleen. These results confirm
previous findings by Ruckwardt et al. albeit with some differ-
ences. In their model, the peak of CD4 Foxp3 CD25
nTreg accumulation appeared on day 6 p.i. in the lung, with
only slight increases in nTreg numbers in the MLN and no
increase detected in the spleen (20). Furthermore, we have
shown for the first time the dynamic changes of CD4 Foxp3
CD25 nTregs that occur in the BAL fluid during RSV infec-
tion.
To study the role of CD4 Foxp3 CD25 nTregs in RSV
infection, we effectively depleted these cells by anti-CD25 an-
tibody treatment prior to infection. Interestingly, depletion
using this antibody appeared to be more effective at removing
CD4 Foxp3 CD25 nTregs in the BAL fluid than in the
lung. This may be due to the fact that there are fewer cells in
the BAL fluid overall and, therefore, fewer CD4 Foxp3
CD25 nTregs to remove. Depletion resulted in increased
weight loss and delayed recovery. Weight loss was accompa-
nied by increases in numbers of innate immune cells in the
BAL fluid and lung on day 8 p.i. This novel finding indicates
that CD4 Foxp3 CD25 nTregs play a critical role in lim-
iting either the recruitment, proliferation, or clearance of in-
nate cells from the lung following RSV infection. Several stud-
ies have indeed demonstrated that Tregs are able to inhibit
neutrophils and NK cells (6, 13). Therefore, a lack of Tregs in
the lung could lead to a reduced apoptosis of newly activated
neutrophils, and this may have led to their continued presence
and accumulation in the BAL fluid and lung on day 8 p.i.
Several clinical studies have demonstrated that neutrophils are
the predominant cell type found in BAL fluid from infants
hospitalized for severe RSV bronchiolitis (16). In addition, we
have previously shown that NK cells can also contribute to
RSV disease (7). It is possible that the severity of RSV disease
seen in these infants is due to an imbalance or reduction in
Treg numbers or function, which leads to an inability to regu-
late the innate immune response during infection.
The enhanced RSV disease in the absence of CD4 Foxp3
CD25 nTregs could also be attributed to increases in both
CD4 and CD8 T cell responses in the lung, since Tregs are
known to control effector T cell proliferation (17). Interest-
ingly, in the absence of CD4 Foxp3 CD25 nTregs, there
were increases in numbers of CD4 and CD8 T cells producing
IFN- and, possibly more importantly, in numbers of CD4 T
cells coproducing TNF- and IFN-. Furthermore, RSV-spe-
cific CD8 T cell responses with the coproduction of TNF- and
IFN-, induced by restimulation with the RSV-M2 peptide,
were also increased in the absence of nTregs. Taken together,
our findings indicate that CD4 Foxp3 CD25 nTregs con-
trol antiviral, presumably proinflammatory, CD4 and CD8 T
cell responses. Our observations differ to some degree from
results of studies by Ruckwardt et al., who found an increased
RSV-specific production of IFN- but no coproduction of
IFN- and TNF- in CD8 T cells from CD25-depleted RSV-
infected mice (20). These differences may result from the use
of different mouse strains and different CD25 depletion regi-
mens. An increased recruitment of both RSV-specific CD8 and
CD4 T cells has been associated with increased disease severity
(1, 23); however, their role in human disease is controversial
(4, 25). It is likely, in the context of a primary RSV infection,
that the lack of nTregs does play some role in the increased
pathology observed.
Given the increased immune and inflammatory responses,
we predicted that the viral load would be reduced following
Treg depletion. However, the copy numbers of the RSV L gene
on day 4, the peak of RSV replication, and day 8 p.i. in the lung
remained unchanged. This is comparable with data reported
previously by Ruckwardt et al., who found no difference at day
4, 5, or 8 p.i. but did observe an increase in the viral load at
days 6 and 7 p.i. in CD25-depleted mice (20). Similar to our
findings, Tregs do not seem to affect bacterial load either, as
has been shown previously with models of lung infections with
Mycobacterium tuberculosis or Mycobacterium bovis bacillus
Calmette-Gue´rin (19). Together with our findings discussed
above, these observations indicate that nTregs specifically reg-
ulate inflammatory immune responses in RSV infection with-
out inhibiting antiviral responses involved in the control of
RSV replication and its clearance.
Our study approach may have limitations in that the anti-
CD25 antibody treatment used has the potential to deplete
newly activated effector T cells, which upregulate CD25 as well
as Foxp3 CD25 Tregs. However, by depleting naïve mice
prior to infection, we aimed to specifically target nTregs. Sup-
porting this, we found that levels of the early activation marker
CD69 remained similar on both CD4 and CD8 T cells from
CD25-depleted mice and controls. Importantly, CD4 and CD8
T cell numbers were increased in CD25-depleted mice, as was
their effector T cell function, such as the production of IFN-.
The recent development of “knock-in” mice expressing a diph-
theria toxin receptor and green fluorescent protein, under the
control of the Foxp3 locus, allows the specific, inducible deple-
tion of Foxp3 cells (11, 12) and may prove useful in further
refining our understanding of Treg functions in respiratory
viral infections.
In summary, we have shown that the local CD4 Foxp3
CD25 nTreg population, from draining lymph nodes to bron-
choalveolar lavage fluid, expands following RSV infection of
the lung. These CD4 Foxp3 CD25 nTregs appear to
dampen both innate and adaptive immune responses, and in
their absence, immunopathology and RSV disease are en-
hanced, and recovery is delayed. This highlights the impor-
tance of CD4 Foxp3 CD25 nTregs in regulating virus-
induced lung inflammation, and through studying regulatory
mechanisms further, we may better understand why some in-
fants suffer severe, prolonged illness with secondary complica-
tions, while the majority recover rapidly from RSV infection. It
may be that exploiting this pathway could allow us to develop
new therapeutic strategies targeted at reducing immune-medi-
ated damage of the lungs.
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